Clinical and Translational Science Center
临床和转化科学中心
基本信息
- 批准号:10673813
- 负责人:
- 金额:$ 996.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-05 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdoptionAnimalsAreaAtmosphereAwardBioinformaticsBiomedical ResearchCOVID-19 pandemicCenter for Translational Science ActivitiesChildCitiesClinicClinicalClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesCommunity HealthCommunity NetworksCommunity OutreachComputer softwareCountryDevelopmentDevice or Instrument DevelopmentDisciplineDiseaseEducationEducational process of instructingElderlyEnsureEntrepreneurshipEthicsFosteringFundingFutureFuture GenerationsGenerationsGoalsHealthHomeHospitalsHumanInformaticsInfrastructureInstitutionMedical centerMedicineMemorial Sloan-Kettering Cancer CenterMulti-Institutional Clinical TrialNew YorkNew York CityOperative Surgical ProceduresOrthopedicsPathway interactionsPopulationPresbyterian ChurchPreventive MedicineProcessProgram DevelopmentPublic HealthPublished CommentRadialResearchResearch PersonnelResearch TrainingResourcesSchool NursingScienceSelf StimulationSeriesSiteSpecial HospitalsSpecial PopulationStrategic PlanningStudentsSystemTNFSF15 geneTrainingTranslatingTranslational ResearchUniversitiesVaccinationWalkingWorkbasecareercareer developmentclinical translationcollaborative environmentcollegecommunity based participatory researchcommunity engagementcommunity organizationscomputing resourcesdesigndisabilityequity, diversity, and inclusionethnic minoritygraduate schoolhackathonhealth disparityhealth inequalitieshigh standardimprovedinnovationinventionlecturesmedical schoolsmultidisciplinarynovelopioid epidemicoutreachpandemic impactprecision medicineprogramsracial minorityresearch studysymposiumsynergismtherapeutic developmenttranslational research programtranslational studyunderserved areaunderserved communityurban public healthurban schoolvaccine hesitancyvirtualweb portal
项目摘要
Contact PD/PI: IMPERATO-MCGINLEY, JULIANNE L
OVERALL
PROJECT SUMMARY/SUMMARY
The Weill Cornell Medicine Clinical and Translational Science Center’s (CTSC) future strategies are built on the
considerable accomplishments achieved over the last 14 years, providing the translation of research and the
generation of research ideas that pave the way for future innovations despite the effect of the pandemic on the
medical school, with the city in lockdown for over 14 months. The plans for the next five years are devised to
continue to develop the existing infrastructure and its initiatives, to add new ones, to enhance networking, and
to improve diversity, equity, and inclusion. In so doing, we will continue to advance translational science to
improve community health. With our multi-institutional hub of distinguished partners firmly in place, the strategic
plans for the CTSC are geared to rapidly advance translational science discovery by: 1) Enhancing informatics
to increase resource adoption, reduce roadblocks and streamline workflow through training, novel software, and
new collaborations; 2) Improving health inequities, developing strong translational research engagement with
communites, and preparing for health crises, like the COVID-19 pandemic, where the CTSC organized a
vaccination hesitancy program and set up vaccination sites in underserved communities; 3) Continuing to
develop our highly successful clinical and translational education programs through innovative and
entrepreneurial multifaceted initiatives including training in health disparities and a new cross-hub KL2/TL1
collaboration with the Georgetown/Howard CTSA; and 4) Creating Team Science initiatives that promote
inclusion across the CTSC. Innovative didactic opportunities will continue to be offered and expanded, such as
seminars on innovation and entrepreneurship, the newest of which will be a collaborate with eLab on “Unmet
Needs for Stimulating Device Development,” a five-part series which is designed to stimulate device
development. The Pilot Translational and Clinical Studies program will be enhanced to target projects in device
and therapeutics development, precision medicine and research in special populations while promoting
collaborations between the community, community organizations and CTSC Investigators. The CTSC also offers
educative opportunities that reach the broader community such as our Teaching Ethics Through Art program,
while the Special Population Network (SPN) will expand to include community outreach studies and continue
clinical research studies with a focus on the following populations: children, the elderly, ethnic and racial
minorities and those with disabilities. Additionally, the Network Capacity Component will do more outreach to
encourage local investigators to initiate multi-center clinical trials. The CTSC has also been extremely successful
ensuring the availability of biostatisticians from all partners with expertise in diverse disease systems and with
adequate computational resources to support the design and conduct of research studies performed within the
CTSC. All of these initiatives allow the CTSC to accomplish its goal of translating science to improve public
health more effectively and efficiently.
Project Summary/Abstract Page 298
Contact PD/PI: IMPERATO-MCGINLEY, JULIANNE L
联系PD/PI:Imperato-Mcginley,Julianne L
全面的
项目摘要/摘要
Weill Cornell Medicine临床和转化科学中心(CTSC)的未来策略是建立在
在过去的14年中取得了相当大的成就,提供了研究的翻译和
尽管大流行对未来的创新铺平道路的一系列研究思想
医学院,纽约市在锁定中呆了14个月以上。未来五年的计划被设计为
继续开发现有的基础架构及其计划,以添加新基础架构,以增强网络和
改善多样性,公平性和包容性。这样,我们将继续将转化科学推向
改善社区健康。凭借我们杰出合作伙伴的多机构中心,该战略首先
CTSC的计划旨在快速推进转化科学发现:1)增强信息信息
为了增加资源采用,通过培训,新软件和
新合作; 2)改善健康不平等,发展强大的转化研究参与
社区,并为健康危机做准备,例如COVID-19大流行,CTSC组织了
疫苗接种犹豫计划并在服务不足的社区中建立疫苗接种地点; 3)继续
通过创新和
企业家多基础计划,包括健康分配培训和新的横毂KL2/TL1
与乔治敦/霍华德CTSA的合作; 4)创建促进的团队科学计划
包含在整个CTSC中。创新的教学机会将继续提供和扩展,例如
关于创新和企业家精神的半手,最新的将是与Elab合作的
刺激设备开发的需求,“旨在刺激设备的五部分系列
发展。试点翻译和临床研究计划将增强设备中的目标项目
以及促进特殊人群的治疗开发,精确医学和研究
社区,社区组织和CTSC调查人员之间的合作。 CTSC也提供
教育机会,通过艺术计划,诸如我们的教学道德等更广泛的社区,
而特殊人口网络(SPN)将扩展到包括社区外展研究并继续
临床研究的重点是以下人群:儿童,年长,种族和种族
少数民族和残疾人。此外,网络容量组件将对
鼓励当地研究人员启动多中心临床试验。 CTSC也非常成功
确保所有合作伙伴的生物统计学家的可用性
足够的计算资源,以支持在内部进行的研究和进行研究
CTSC。所有这些举措允许CTSC完成翻译科学以改善公众的目标
健康更有效地有效。
项目摘要/摘要页面298
联系PD/PI:Imperato-Mcginley,Julianne L
项目成果
期刊论文数量(603)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer.
- DOI:10.1016/j.ygyno.2022.10.012
- 发表时间:2022-12
- 期刊:
- 影响因子:4.7
- 作者:Rubinstein, Maria;Shen, Sherry;Monk, Bradley J.;Tan, David S. P.;Nogueira-Rodrigues, Angelica;Aoki, Daisuke;Sehouli, Jalid;Makker, Vicky
- 通讯作者:Makker, Vicky
Unmet mental health needs in patients with advanced B-cell lymphomas.
- DOI:10.1017/s1478951521001164
- 发表时间:2022-06
- 期刊:
- 影响因子:2.2
- 作者:Marte, Chrystal;George, Login S.;Rutherford, Sarah C.;Ouyang, Daniel Jie;Martin, Peter;Leonard, John P.;Trevino, Kelly M.
- 通讯作者:Trevino, Kelly M.
Obstetrical Complications and Long-Term Cardiovascular Outcomes.
- DOI:10.1007/s11906-020-01102-9
- 发表时间:2020-09-17
- 期刊:
- 影响因子:5.6
- 作者:Savage M;Steitieh D;Amin N;Malha L;Chasen S
- 通讯作者:Chasen S
Research Priorities for Plasma and Platelet Transfusion Strategies in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.
- DOI:10.1097/pcc.0000000000002859
- 发表时间:2022-01-01
- 期刊:
- 影响因子:0
- 作者:Nellis ME;Remy KE;Lacroix J;Cholette JM;Bembea MM;Russell RT;Steiner ME;Goobie SM;Vogel AM;Crighton G;Valentine SL;Delaney M;Parker RI;Pediatric Critical Care Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding (TAXI-CAB), in collaboration with the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
- 通讯作者:Pediatric Critical Care Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding (TAXI-CAB), in collaboration with the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Underrepresentation of racial and ethnic minorities in cascade testing for hereditary cancer syndromes.
- DOI:10.1038/s41431-023-01364-2
- 发表时间:2023-07
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIANNE L IMPERATO-MCGINLEY其他文献
JULIANNE L IMPERATO-MCGINLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIANNE L IMPERATO-MCGINLEY', 18)}}的其他基金
Disparities in COVID Disease Severity and Outcomes in New York City
纽约市新冠疾病严重程度和结果的差异
- 批准号:
10159057 - 财政年份:2017
- 资助金额:
$ 996.71万 - 项目类别:
Clinical and Translational Science Center (UL1)
临床和转化科学中心 (UL1)
- 批准号:
8140982 - 财政年份:2010
- 资助金额:
$ 996.71万 - 项目类别:
相似国自然基金
臂旁核区域损伤致长时程“昏迷样”动物模型建立及神经机制研究
- 批准号:81901068
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
三江源大型野生食草动物对区域草畜平衡状态影响及管控机制研究
- 批准号:41971276
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
基于组蛋白H3K9me3和DNA甲基化修饰协同作用研究早期胚胎发育过程中基因印记区域的调控
- 批准号:31801059
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
使用三代测序技术研究线粒体DNA非编码区域对其DNA复制和转录的调控
- 批准号:31701089
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
转录因子Msx1与哺乳动物上腭发育的前-后区域化
- 批准号:31771593
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Crossroads: Using decision making strategies to develop high impact content for training in rigor and transparency.
十字路口:使用决策策略来开发高影响力的内容,以进行严格和透明的培训。
- 批准号:
10722510 - 财政年份:2023
- 资助金额:
$ 996.71万 - 项目类别:
On Demand Dissoluble Supramolecular Hydrogels: Towards Pain Free Burn Dressings
按需可溶性超分子水凝胶:迈向无痛烧伤敷料
- 批准号:
10658220 - 财政年份:2023
- 资助金额:
$ 996.71万 - 项目类别:
A stakeholder derived intervention to enhance technology engagement and reduce the emotional divide in distance caregiving of older adults with cognitive impairment
利益相关者衍生的干预措施,旨在提高技术参与度并减少对患有认知障碍的老年人进行远程护理时的情感鸿沟
- 批准号:
10572911 - 财政年份:2023
- 资助金额:
$ 996.71万 - 项目类别:
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology
用于功能性精准肿瘤学的细胞状态动力学定量成像 (QuICK) 的开发和临床前验证
- 批准号:
10737379 - 财政年份:2023
- 资助金额:
$ 996.71万 - 项目类别:
Investigating mechanisms mediating enhanced THC reinforcement by nicotine
研究尼古丁增强 THC 增强作用的机制
- 批准号:
10739859 - 财政年份:2023
- 资助金额:
$ 996.71万 - 项目类别: